{
  "id": 18009813,
  "title": "Transforming pandemic influenza antiviral stockpiling using a capacity-based approach: A modeling study",
  "url": "https://urgent.news/2026/11/03/transforming-pandemic-influenza-antiviral-stockpiling-using-a",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-03T14:00:00.000Z",
  "source": {
    "name": "PLOS Medicine",
    "slug": "plos-medicine",
    "url": "https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004992"
  },
  "original_language": "en",
  "account": "Pandemic influenza preparedness in high-income countries has historically depended on extensive antiviral stockpiles, usually aiming to cover 25% of the populace. This inventory-centric benchmark prioritizes overall disease reduction but frequently neglects the fixed capacity of healthcare systems to handle sudden patient surges. As significant inventories near their expiration dates, researchers explored if static stockpiles are still a suitable strategy for averting healthcare system overloads during future pandemics.\n\nTo address this query, investigators simulated daily hospital bed demand by utilizing three interconnected models: a static lower-bound estimate, a deterministic Susceptible-Infectious-Hospitalized-Recovered transmission model, and historical examinations of the 1918, 1957, and 1968 pandemics using mortality data. They assessed official planning scenarios for the United Kingdom, Japan, and the United States, juxtaposing projected demand against national surge capacities (i.e., staffed hospital beds).\n\nTo assess the practical limits of the stockpile strategy, researchers applied favorable assumptions, comprising flawless distribution of antivirals to 100% of symptomatic cases and high clinical efficiency (30% to 60% reduction in hospitalization). Their models identified a critical feasibility gap. Although stockpiles efficiently lowered demand to manageable levels in moderate scenarios (akin to 1957/1968), they were inadequately prepared for severe events. In high-severity scenarios (akin to 1918 or CDC Very Severe parameters), the daily influx of patients surpassed available hospital capacity by a factor of 5–9. This overcapacity surfaced even when presuming 100% treatment coverage, rendering antivirals unable to avert the shift to crisis standards of care.\n\nAlthough this study is limited by its inherent optimistic bias, specifically the usage of a conservative 4-day hospital length of stay that undervalues prolonged intensive care requirements, the reliance on general hospital beds as a proxy that abstracts away from critical subsystem bottlenecks, and the assumption of guaranteed antiviral efficacy against novel strains, the researchers posit that the discovered structural failings serve as a conservative estimate. Considering the potential operational difficulties, these discrepancies between stockpile targets and system capacity would likely widen in reality.\n\nThe primary limitation of this study's methodology is its optimistic bias, namely the conservative 4-day hospital length of stay that underestimates prolonged intensive care demands, the reliance on general hospital beds as a proxy that abstracts away from critical system bottlenecks, and the assumption of assured antiviral effectiveness against new strains.\n\nIn conclusion, this study reveals that substantial reserves cannot overcome the rigid physical constraints of healthcare systems, even under the optimistic assumption of flawless distribution. As a result, the traditional 25% coverage goal for antiviral stockpiles, a staple of traditional planning, necessitates a critical reassessment. As global stocks approach expiration, policymakers are ideally positioned to capitalize on this juncture by investigating a capacity-based framework. This adaptive strategy proposes integrating a blend of targeted reserves, temporary non-pharmaceutical interventions, and flexible delivery options, such as decentralized home-based care. By amalgamating these complementary approaches, policymakers can form a crucial temporal buffer, safeguarding healthcare system resilience until vaccine deployment becomes feasible.",
  "summary": "by Nir Gavish, Amit Huppert Background Pandemic influenza preparedness in high-resource nations has traditionally relied on large antiviral stockpiles, typically targeting coverage for 25% of the population. This inventory-based benchmark focuses on cumulative disease burden but often overlooks the inelastic capacity of healthcare systems to manage acute surges. As multi-billion-dollar…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}